1. Nishimura A, et al: Development of Quality Indicators of Stroke Centers and Feasibility of Their Measurement Using a Nationwide Insurance Claims Database in Japan ― J-ASPECT Study ―. Circ J 2019 Oct 25;83(11):2292-2302.
2. V Mantero, C Scaccabarozzi, E Botto, G Giussani, A Aliprandi, A Lunghi, E Ciusani, G Brenna, A Salmaggi, et al: Outcome in Lacunar Stroke: A Cohort Study. Acta Neurol Scand. 2018 Oct;138(4):320-326.
3. Bliss TM, Andres RH, Steinberg GK, et al: Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis 2010;37:275-283
4. Abe K, Yamashita T, Takizawa S, Kuroda S, Kinouchi H, Kawahara N, et al:Stem cell therapy for cerebral ischemia: From basic science to clinical applications. J Cereb Blood Flow Metab. 2012;32:1317-1331
5. Kushida Y, Wakao S, Dezawa M, et al:Muse cells are endogenous reparative stem cells. Adv Exp Med Biol 2018;1103:43-68
6. Kuroda Y, Kitada M, Wakao S, Nishikawa K, Tanimura Y, Makinoshima H, et al: Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci U S A 2010;107:8639-8643
7. Kuroda Y, Wakao S, Kitada M, Murakami T, Nojima M, Dezawa M, et al: Isolation, culture and evaluation of multilineage-differentiating stress-enduring (muse) cells. Nat Protoc 2013;8:1391-1415
8. Wakao S, Kitada M, Kuroda Y, Shigemoto T, Matsuse D, Akashi H, et al: Multilineage-differentiating stress-enduring (muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc Natl Acad Sci U S A 2011;108:9875-9880
9. Hori E, Hayakawa Y, Hayashi T, Hori S, Okamoto S, Shibata T, et al: Mobilization of pluripotent multilineage-differentiating stress-enduring cells in ischemic stroke. J Stroke Cerebrovasc Dis 2016;25:1473-1481
10. Tanaka T, Nishigaki K, Minatoguchi S, Nawa T, Yamada Y, Kanamori H, et al: Mobilized muse cells after acute myocardial infarction predict cardiac function and remodeling in the chronic phase. Circ J 2018;82:561-571
11. Yamada Y, Wakao S, Kushida Y, Minatoguchi S, Mikami A, Higashi K, et al: S1P- S1PR2 axis mediates homing of muse cells into damaged heart for long-lasting tissue repair and functional recovery after acute myocardial infarction. Circ Res 2018;122:1069-1083
12. Katagiri H, Kushida Y, Nojima M, Kuroda Y, Wakao S, Ishida K, et al: A distinct subpopulation of bone marrow mesenchymal stem cells, muse cells, directly commit to the replacement of liver components. Am J Transplant 2016;16:468-483
13. Iseki M, Kushida Y, Wakao S, Akimoto T, Mizuma M, Motoi F, et al: Muse cells, nontumorigenic pluripotent-like stem cells, have liver regeneration capacity through specific homing and cell replacement in a mouse model of liver fibrosis. Cell Transplant 2017;26:821-840
14. Uchida N, Kushida Y, Kitada M, Wakao S, Kumagai N, Kuroda Y, et al: Beneficial effects of systemically administered human muse cells in adriamycin nephropathy. J Am Soc Nephrol 2017;28:2946-2960
15. Hosoyama K, Wakao S, Kushida Y, Ogura F, Maeda K, Adachi O, et al:Intravenously injected human multilineage-differentiating stress-enduring cells selectively engraft into mouse aortic aneurysms and attenuate dilatation by differentiating into multiple cell types. J Thorac Cardiovasc Surg 2018;155:2301- 2313 e2304
16. Uchida H, Morita T, Niizuma K, Kushida Y, Kuroda Y, Wakao S, et al: Transplantation of unique subpopulation of fibroblasts, muse cells, ameliorates experimental stroke possibly via robust neuronal differentiation. Stem Cells 2016;34:160-173
17. Uchida H, Niizuma K, Kushida Y, Wakao S, Tominaga T, Borlongan CV, et al: Human muse cells reconstruct neuronal circuitry in subacute lacunar stroke model. Stroke. 2017;48:428-435
18. Uchida H, Sakata H, Fujimura M, Niizuma K, Kushida Y, Dezawa M, et al: Experimental model of small subcortical infarcts in mice with long-lasting functional disabilities. Brain Res 2015;1629:318-328
19. Li X, Blizzard KK, Zeng Z, DeVries AC, Hurn PD, McCullough LD, et al: Chronic behavioral testing after focal ischemia in the mouse: Functional recovery and the effects of gender. Exp Neurol 2004;187:94-104
20. Balkaya M, Krober JM, Rex A, Endres M, et al:Assessing post-stroke behavior in mouse models of focal ischemia. J Cereb Blood Flow Metab 2013;33:330-338
21. Cummings BJ, Uchida N, Tamaki SJ, Salazar DL, Hooshmand M, Summers R, et al: Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci U S A 2005;102:14069-14074
22. Saito K, Chang YF, Horikawa K, Hatsugai N, Higuchi Y, Hashida M, et al: Luminescent proteins for high-speed single-cell and whole-body imaging. Nat Commun 2012;3:1262
23. STEPS Participants, et al: Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke 2009; 40:510‒515.
24. Savitz SI, Chopp M, Deans R, Carmichael T, Phinney D, Wechsler L et al: STEPS Participants et al: Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II. Stroke 2011; 42:825‒829.
25. Savitz SI, Cramer SC, Wechsler L, et al: STEPS 3 Consortium. Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials. Stroke 2014; 45:634‒639.
26. Horie N, Maag AL, Hamilton SA, Shichinohe H, Bliss TM, Steinberg GK, et al: Mouse model of focal cerebral ischemia using endothelin-1. J Neurosci Methods 2008; 173:286‒290.
27. Blomstrand F, Venance L, Sirén AL, Ezan P, Hanse E, Glowinski J, et al. Endothelins regulate astrocyte gap junctions in rat hippocampal slices. Eur J Neurosci 2004; 19:1005‒1015.
28. Kondziolka D, Wechsler L, Goldstein S, Meltzer C, Thulborn KR, Gebel J, et al: Transplantation of cultured human neuronal cells for patients with stroke. Neurology 2000;55:565-569
29. Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, Gebel J, et al: Neurotransplantation for patients with subcortical motor stroke: A phase 2 randomized trial. J Neurosurg 2005;103:38-45
30. Rabinovich SS, Seledtsov VI, Banul NV, Poveshchenko OV, Senyukov VV, Astrakov SV, et al: Cell therapy of brain stroke. Bull Exp Biol Med 2005;139:126-128
31. Savitz SI, Dinsmore J, Wu J, Henderson GV, Stieg P, Caplan LR, et al: Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: A preliminary safety and feasibility study. Cerebrovasc Dis 2005;20:101-107
32. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, et al: Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc Natl Acad Sci U S A 2000;97:12846-12851
33. Amariglio N, Hirshberg A, Scheithauer BW, Cohen Y, Loewenthal R, Trakhtenbrot L, et al: Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 2009;6:e1000029
34. Bang OY, Lee JS, Lee PH, Lee G, et al:Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005;57:874-882
35. Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY, et al: A long-term follow- up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 2010;28:1099-1106
36. Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S, Onodera R, et al: Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 2011;134:1790-1807
37. Battistella V, de Freitas GR, da Fonseca LM, Mercante D, Gutfilen B, Goldenberg RC, et al:Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen Med 2011;6:45-52
38. Bersano A, Ballabio E, Lanfranconi S, Boncoraglio GB, Corti S, Locatelli F, et al:Clinical studies in stem cells transplantation for stroke: A review. Curr Vasc Pharmacol 2010;8:29-34
論文の公開元へ
